stockrow
Friday 6 November 2026
Export QSI’s income statement to Excel — free account
Quantum-Si Incorporated
QSI Healthcare Medical Devices
Quantum-Si Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, down 20.3% from fiscal 2024.
- Revenue
- −61.6%
- EPS
- +41.2%
- Free cash flow
- +37.5%
Quarter to September 2026, against a year earlier
1.32
0.15
+12.82%
Follow QSI
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 2 | 3 | 3 |
| (46.52%) | (46.38%) | (49.11%) | (43.06%) | ||
| (41.07%) | (42.85%) | (43.98%) | (39.32%) | ||
ROIC |
(126.60%) | (97.95%) | (100.92%) | (104.20%) | |
Return on Tangible Assets |
(61.04%) | (76.18%) | (83.46%) | (77.20%) | |
Average Days of Receivables |
779.00 | 40.01 | 12.96 | 0.00 | |
Free Cash Flow per Share |
(0.49) | (0.44) | (0.43) | (0.37) | |
Free Cash Flow |
(97.23) | (95.69) | (93.69) | (81.35) | |
Capital Expenditures |
(2.52) | (1.49) | (1.24) | (0.43) | |
| Other line items | |||||
Cash ROIC |
(25.38%) | (29.17%) | (32.09%) | (30.85%) | |
Accounts Receivable Turnover |
0.75 | 3.00 | 0.57 | 0.00 | |
Accounts Payable Turnover |
0.72 | 0.60 | 0.55 | 0.60 | |
Inventory Turnover |
0.35 | 0.34 | 0.35 | 0.32 | |
Average Days of Payables |
461.73 | 588.07 | 556.77 | 624.45 | |
Days of Inventory on Hand |
909.51 | 719.82 | 709.35 | 727.34 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2,206.86% | 2,944.33% | 3,435.51% | 4,350.67% | |
Selling, General and Administrative Expense of Revenue |
1,837.19% | 2,295.52% | 2,529.22% | 3,158.74% | |
Share Based Compensation of Revenue |
442.24% | 592.66% | 693.46% | 880.55% | |
Operating CF/Net income |
0.93 | 0.91 | 0.94 | 0.95 | |
Depreciation/Fixed assets |
(0.27) | (0.17) | (0.05) | 0.11 | |
Capex/Depreciation |
0.71 | 0.74 | 2.18 | (0.40) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(0.48) | (0.44) | (0.42) | (0.37) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Capex to Sales |
1.03 | 0.80 | 0.77 | 0.34 |
Columns are period end dates · fundamentals updated 5 Nov 2026